Brief: Willow And Leading Innovative Biopharmaceutical Company Advance Development Program To Manufacture Sustainable Intermediates And Active Pharmaceutical Ingredients

Atlas Energy

07/12/2023 12:07

Dec 7 (Reuters) - Willow Biosciences Inc  WLLW.TO :
    * WILLOW AND LEADING INNOVATIVE BIOPHARMACEUTICAL COMPANY
ADVANCE
DEVELOPMENT PROGRAM TO MANUFACTURE SUSTAINABLE INTERMEDIATES AND
ACTIVE PHARMACEUTICAL INGREDIENTS
    * WILLOW BIOSCIENCES INC - PROGRAM BRINGS IMMEDIATE RESEARCH
AND
DEVELOPMENT REVENUE AND FIRST COMMERCIAL SUPPLY REVENUE AS EARLY
AS 2024

Source text for Eikon:  ID:nCNWqrJJva 
Further company coverage:  WLLW.TO 

 ((Reuters.Briefs@thomsonreuters.com;))